Cortecs contract

Click to follow
The Independent Online
Cortecs contract

CORTECS, the biotechnology group, yesterday signed a deal with the Spanish drug group, Ferrer, for the distribution of its osteoporosis treatment Macritonin in Latin America. The companies expect sales of around $20m (pounds 12.3m) for the drug in the region in the five years after registration.

Comments